Dr. Cesarman is trained in Anatomic Patology, nbsp;Hematopathology and Molecular Pathology. She serves as Assistant Director of the Molecular Hematopathology Laboratory of the NewYork-Presbyterian Hospital/Weil Cornell Medical College. Dr. Cesarman's research focuses on malignancies associated with AIDS and other immunodeficiencies. Dr. Cesarman is Leader of the Pathology Core for the AIDS Malignancy Consortium and is involved in the diagnosis of these tumors in multiple national and international clinical trials.

Ongoing research in the Cesarman laboratory is aimed at characterizing the oncogenes encoded by KSHV and EBV, with the goal of dissecting the mechanism of transformation by these viruses and understanding their role in the development of malignant lymphoma or Kaposi's sarcoma. By characterizing the viral proteins that provide survival signals to the tumor cells, we are better understanding the role they play in carcinogenesis. The laboratory is currently developing inhibitors to these oncogenic viral proteins as a novel approach for the treatment of EBV- and KSHV-related malignancies.